News search
 About the CNIC 8 Sep 2016 First call for proposals to access the ReDIB Singular Scientific-Technological Infrastructure (SSTI) ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián |
 Research 8 Sep 2016 The study, published in Nature Communications, reveals these cells as a possible target for cardiovascular cell therapy |
 Research 23 Aug 2016 Journal of the American College of Cardiology (JACC) Publishes Data Assessing the Impact of Medication Adherence on Long-term Cardiovascular Outcomes and Cost |
 Research 7 Jul 2016 The study, published in Nature, provides information with important implications for mitochondrial donation therapies, which produce children with three genetic parents |
 Research 5 Jul 2016 The study, published in Nature Immunology, opens the way to the possible use of CD69 as a therapeutic target for the control of this disease |
 Research 28 Jun 2016 Nature Immunology: Changes to mitochondrial metabolism allow the immune system to adapt to infection CNIC scientists reveal how changes in the metabolism of mitochondria allow the cells of the immune system to adapt to living or dead bacteria |
 Research 24 May 2016 Half of patients with CVD show no above-normal risk of developing the disease on the basis of classical risk factors, such as high cholesterol, smoking, lack of exercise, and high blood pressure |
 About the CNIC 11 May 2016 The results could form the basis for the development of future interventions in certain heart conditions and myopathies |
 About the CNIC 25 Apr 2016 These genes form part of a signaling mechanism that is possibly altered in patients with a bicuspid aortic valve (BAV), a prevalent condition that compromises cardiovascular health |
 Research 20 Apr 2016 The protein Aurora A controls the initial phases of T lymphocyte activation |
- ‹ previous
- 25 of 43
- next ›
